FMP

FMP

Enter

ATXS - Astria Therapeutics,...

Financial Summary of Astria Therapeutics, Inc.(ATXS), Astria Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and c

photo-url-https://financialmodelingprep.com/image-stock/ATXS.png

Astria Therapeutics, Inc.

ATXS

NASDAQ

Astria Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare and niche allergic, and immunological diseases in the United States. Its lead product candidate is STAR-0215, a monoclonal antibody inhibitor of plasma kallikrein, which is in preclinical development stage for the treatment of hereditary angioedema. The company was formerly known as Catabasis Pharmaceuticals, Inc. and changed its name to Astria Therapeutics, Inc. in September 2021. Astria Therapeutics, Inc. was incorporated in 2008 and is based in Boston, Massachusetts.

9 USD

-0.64 (-7.11%)

About

ceo

Ms. Jill C. Milne Ph.D.

sector

Healthcare

industry

Biotechnology

website

https://www.astriatx.com

exchange

NASDAQ

Description

Astria Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare and niche allergic, and immunological diseases in the United States. Its lead product candidate is STAR-0215, a monoclonal antibody inhibitor of plasma kallikrein, which is in preclinical development stage for the treatment of hereditary angioedema. The company was formerly known as Catabasis Pharmaceuticals, Inc. and changed its name to Astria Therapeutics, Inc. in September 2021. Astria Therapeutics, Inc. was incorporated in 2008 and is based in Boston, Massachusetts.

CIK

0001454789

ISIN

US04635X1028

CUSIP

04635X102

Address

100 High Street

Phone

617 349 1971

Country

US

Employee

59

IPO Date

Jun 25, 2015

Summary

CIK

0001454789

Exchange

NASDAQ

Industry

Biotechnology

Sector

Healthcare

CUSIP

04635X102

ISIN

US04635X1028

Country

US

Price

9

Beta

0.71

Volume Avg.

1.07M

Market Cap

494.13M

Shares

-

52-Week

4.26-16.9

DCF

5.82

ROE

-

ROA

-

Operating Margin

-

Debt/Equity

-

P/E

-3.72

P/B

-

Website

https://www.astriatx.com

Historical Prices

We are unable to load the chart at this time.

fmp-logo

Financial Statement

We are unable to load the chart at this time.

fmp-logo

Earnings

We are unable to load the chart at this time.

fmp-logo

Upgrades and Downgrades

We are unable to load this data!

fmp-logo

People Also Watch

page loading card

Latest ATXS News

It looks like there's no news available.

fmp-logo
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep